tirzepatide and osa Semaglutide: Impact on in Obesity Obstructive Sleep Apnea | 2

Once you've injected the delayed dose, resume your normal weekly schedule from that new injection datethis becomes your new anchor day going forward for the next week

AMPK signaling in energy control, cartilage biology, and osteoarthritis

GLP-1 Friendly Recipe Ideas to Help You Get Started

GLP-1 medications deliver substantially greater weight loss: semaglutide trials showed 1015% body weight reduction over 68 weeks, and tirzepatide (a dual GLP-1/GIP agonist) demonstrated 20%+ reductions in some cohorts

Schedule a free consultation now to start a weight loss journey with confidence and professional support

To minimise side effects and allow the body to acclimatise to the medication, it is recommended to start semaglutide at a low dose of 0.25mg or 0.5mg per week for 1 month, before increasing to a medium dose of 1mg per week